Добірка наукової літератури з теми "Facteur de risque génétique"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Facteur de risque génétique".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Facteur de risque génétique":
Benmoussa, Mahfoud Cherif, Riad Grari, Rawda Sari Hamidou, and Mustapha Benmansour. "Genetics and epigenetics at the service of kidney diseases." Batna Journal of Medical Sciences (BJMS) 2, no. 1 (June 30, 2015): 50–55. http://dx.doi.org/10.48087/bjmstf.2015.2112.
JULIAN-REYNIER, Claire, Jean-Paul MOATTI, Pascale BOURRET, François EISINGER, and Hagay SOBOL. "Vers une colonisation génétique de la médecine?" Sociologie et sociétés 28, no. 2 (September 30, 2002): 141–55. http://dx.doi.org/10.7202/001368ar.
Taleb, M. "SFAP – La consanguinité : risque d’anomalies génétiques." European Psychiatry 30, S2 (November 2015): S84—S85. http://dx.doi.org/10.1016/j.eurpsy.2015.09.371.
Leboyer, M., and F. Clerget-Darpoux. "Génétique et psychiatrie : une nouvelle approche de l’étiopathogénie des maladies mentales ?" Psychiatry and Psychobiology 3, no. 2 (1988): 69–72. http://dx.doi.org/10.1017/s0767399x00001838.
Gilgenkrantz, S. "Athérosclérose et hyperhomocystéinémie : un facteur de risque génétique à prendre désormais en compte." médecine/sciences 12, no. 5 (1996): 649. http://dx.doi.org/10.4267/10608/798.
Dussault, Frédéric, Frank Vitaro, Mara Brendgen, Michel Boivin, Jean R. Séguin, and Ginette Dionne. "Chevauchement entre les trajectoires de jeu et les trajectoires de consommation de psychotropes au début de l’adolescence : une étude longitudinale génétiquement informative." Drogues, santé et société 12, no. 2 (October 14, 2014): 20–46. http://dx.doi.org/10.7202/1026876ar.
Manus, Jean-Marie. "L’APOE4 serait-il le facteur de risque génétique le plus important pour la maladie d’Alzheimer ?" Revue Francophone des Laboratoires 2022, no. 548 (January 2023): 11. http://dx.doi.org/10.1016/s1773-035x(22)00385-9.
Chentouf, A. "Consanguinité et prédisposition génétique à l’épilepsie." European Psychiatry 30, S2 (November 2015): S85—S86. http://dx.doi.org/10.1016/j.eurpsy.2015.09.374.
Dotché, Ignace Ogoudanan, Karamatou Bio Seydou, Amen Gloria Gwladys Ahouanse, Emmanuel Tohoun, Boris Constant Bankolé, and Issaka Youssao Abdou Karim. "Comment concevoir la biosécurité des élevages porcins des milieux lacustres du sud Bénin pour réduire le risque de maintien et de dissémination de la peste porcine africaine ?" Cahiers Agricultures 30 (2021): 32. http://dx.doi.org/10.1051/cagri/2021018.
Chader, Henni, and Hocine Gacem. "Impact of solar radiation on health." Batna Journal of Medical Sciences (BJMS) 7, no. 2 (November 9, 2020): 151–58. http://dx.doi.org/10.48087/bjmsra.2020.7219.
Дисертації з теми "Facteur de risque génétique":
Lecarpentier, Julie. "Étude des facteurs modificateurs du risque de cancer du sein des femmes à risque génétique élevé." Phd thesis, Université Paris Sud - Paris XI, 2012. http://tel.archives-ouvertes.fr/tel-00910388.
Haddy, Nadia. "Inflammation, athérosclérose et leurs indicateurs de risque : interleukine-6, facteur de nécrose tumorale-alpha et apolipoprotéine-E." Nancy 1, 2003. http://www.theses.fr/2003NAN12510.
Eichenbaum-Voline, Sophie. "Détection et exclusion de facteurs de risque génétiques dans les maladies multifactorielles application à l'étude du déterminisme de la sclérose en plaques." Paris 5, 2000. http://www.theses.fr/2000PA05S003.
Bouchard-Mercier, Annie. "Génétique, acides gras oméga-3 et facteurs de risque des maladies cardiovasculaires." Doctoral thesis, Université Laval, 2015. http://hdl.handle.net/20.500.11794/25719.
Chronic diseases such as cardiovascular diseases (CVD) are complex and their risk factors are regulated by many factors, for example the genetic background and dietary intakes. In this project, 210 participants were recruited. Two dietary factors were identified, the Prudent dietary pattern which was characterised by higher intakes of vegetables, fruits, whole grain products and non-hydrogenated fats and the Western dietary pattern, characterised by higher intakes of refined grain products, desserts, sweets and processed meats. Both dietary patterns modulated the expression of genes related to the immune system, inflammatory response, cancer and/or CVD. The Western dietary pattern was also associated with a metabolite profile which comprised greater concentrations of certain amino acids as well as small chain acylcartinines. To examine the interindividual variability in the response to a nutrient, a 6 week fish oil supplementation was conducted among the 210 participants. SNPs related to genes involved in de novo lipogenesis and fatty acid beta-oxidation (ACLY, ACACA, GCK, RXRA, ACOX1) were associated alone or in an interaction effect with dietary intakes with the plasma triglyceride (TG) response to the fish oil supplementation. The genetic variability within sterol regulatory element binding transcription factor 1 (SREBF1) gene was associated with differences in the response of insulin concentrations following fish oil supplementation. In a second cohort of 691 participants, associations between SNPs, identified in a previous GWAS conducted among the 210 participants supplemented with fish oil, and TG as well as plasma phospholipid fatty acid concentrations were observed. This thesis also comprises a knowledge transfer section where the attitude was identified as the main determinant of the intention of dietitians to discuss nutrigenetics with their patients/clients. Globally, these results demonstrate that dietary patterns modulate the metabolism at several levels and that the response to fish oil is variable depending upon genetic profile and dietary intakes.
Larifla, Laurent. "Associaltion entre facteurs de risque cardio-vasculaire et coronaropathie aux Antilles : rôle du facteur atrial natriurétique et des polymorphismes de son gène dans l'atherothrombose et le remodelage vasculaire." Thesis, Antilles-Guyane, 2012. http://www.theses.fr/2012AGUY0553/document.
In Guadeloupe and Martinique, the low frequency ofcoronary artery disease (CAD) could be related to genetic or ethniefactors and/or specifie distribution ofcardiovascular risk factors (CRFs). Atrial Natriuretic Peptide (ANP) properties and influence of sorne of ANP gene polymorphism that are frequent in populations of African descent could also be involved in CAD occurrence. We retrospectively studied 638 consecutive patients with documented CAO and found a high prevalence of hypertension and diabetes in this population. This study also demonstrated significant differences in the prevalence of CRFs between Afro-Caribbean (AC), Caucasians and Indians migrants. The angiographie analysis of420 patients revealed that in AC, diabetes emerged as the strongest CFR related to the severity ofcoronary lesions while obesity appeared as a protective factor. After transfection by an adenoviral construct carrying the ANP gene, vascular smooth muscle cell proliferation stimulated by 10% fetal calf serum was reduced by 31% and migration by 25%. In vivo, in rat carotid artery model ofvascular injury, neointima formation and intima/media ratio was reduced by 25% and 28% respectively. In a cross-sectional study inc1uding 210 AC diabetics we found an association between rs5065 (22381> C) polymorpbism and the presence of coronary artery disease suggesting that the minor allele could have a protective effect against CAD. The odds ratio for the presence ofCAD in carriers ofthe minor allele ofthis mutation (TC / CC) was 0.50 (0.26-0.96, P = 0.038)
Debette, Stéphanie. "Facteurs de risque de l'athérosclérose carotidienne." Lille 2, 2008. http://www.theses.fr/2008LIL2S058.
Clot, Fabienne. "Etude de la composante génétique de la maladie coeliaque : analyse des gènes HLA de susceptibilité et recherche d'autres facteurs de risque génétique." Paris 11, 2000. http://www.theses.fr/2000PA11T010.
Bourgain, Catherine. "Intérêt des populations à effet fondateur pour la recherche de facteurs de risque génétiques des maladies multifactorielles." Paris 11, 2001. http://www.theses.fr/2001PA11T033.
Abdelmouttaleb, Idrissia. "Évaluation comparative des facteurs de risque nutritionnels, génétiques et inflammatoires de la sténose coronaire." Nancy 1, 1998. http://www.theses.fr/1998NAN10326.
Eysert, Fanny. "Etude des mécanismes impliquant le facteur de risque génétique FERMT2 dans le métabolisme de l’APP et ses conséquences dans le processus physiopathologique de la maladie d’Alzheimer." Thesis, Lille 2, 2019. http://www.theses.fr/2019LIL2S040.
The establishment of genome-wide association study (GWAS) constitutes a major advance for the identification of new genetic susceptibility factors of Alzheimer’s Disease (AD). In contrast with the target gene approach, these analyses are done sans a priori and do not allow us to determine the role of the identified genes in the pathophysiological process of AD. In this context, only performing "post-GWAS analyses" can explain the molecular processes involving these genes. Our laboratory therefore aimed to identify the genetic risk factors identified by GWAS whose expression levels impact the APP metabolism. Moreover, our model allowed us to study the potential involvement of micro-RNAs (miRs) in the dysregulation of the expression of these genes.In this context, we showed that miR-4504, which is overexpressed in the brains of AD patients compared with controls, decreases the expression of FERMT2, a genetic susceptibility factor of AD. Our results show that FERMT2 under-expression is dependent on the presence of a variant (rs7143400) localized in the 3'UTR of FERMT2, which then leads to the modulation of the APP metabolism and the subsequent increase in Aβ peptide secretion.In this project, I was able to show that the effects of FERMT2 on APP metabolism require its direct inter-action with APP. In addition, using a model of primary neurons cultured in microfluidic devices enabled me to study neuronal functions of the FERMT2/APP complex. I was able to determine that FERMT2/APP interaction contributes to the regulation of axonal growth and synaptogenesis. Finally, by analyzing the long-term potentiation in the brains of mice in which FERMT2 under-expression was induced, we show a decrease in synaptic plasticity – potentially the underlying mechanism of the deleterious effect of decreased FERMT2 expression in neurons and of the pathophysiological process of AD.In conclusion, these results suggest that the genetic risk factor FERMT2, regulated by the presence of the functional variant rs7143400 and miR-4504, participates in the pathophysiological process of AD via synaptic alterations in an APP-dependent manner. This work would ultimately lead to a better understanding of the pathophysiological process leading to AD and help characterize new mechanisms involved in synaptic functions
Книги з теми "Facteur de risque génétique":
Cook, Robin. Facteur risque: Roman. Paris: Éd. France loisirs, 2007.
Robin, Cook. Facteur risque: Roman. Paris: Albin Michel, 2006.
Teichler-Zallen, Doris. To test or not to test: A guide to genetic screening and risk. New Brunswick, N.J: Rutgers University Press, 2008.
Teichler-Zallen, Doris. To test or not to test: A guide to genetic screening and risk. New Brunswick, N.J: Thorndike Press, 2009.
Junien, Claudine. Nutrigénétique du risque cardiovasculaire: Terrains génétiques et nutrition. Paris: Editions Tec & Doc, 2003.
Canada. Conseils et vérification Canada. and Protection civile Canada, eds. La gestion des risques biologiques: Plus particulièrement des risques associés à la biotechnologie. Ottawa, Ont: Protection civile Canada, 1995.
Simons, Jacques. Risques biologiques. Paris: INSERM, 1991.
International Conference on Carcinogenesis and Risk Assessment (9th 1995 Austin, Tex.). Etiology of breast and gynecological cancers: Proceedings of the Ninth International Conference on Carcinogenesis and Risk Assessment, held in Austin, Texas, November 29-December 2, 1995. Edited by Aldaz C. Marcelo 1956-. New York: Wiley-Liss, 1997.
Garel, Jean-Pierre. L'horreur génétique: Le droit de savoir, le pouvoir d'agir : clones et transgéniques volent et violent la vie. St-Julien en Genevois [France]: Jouvence, 2001.
Fincham, J. R. S. Genetically engineered organisms: Benefits and risks. Toronto: University of Toronto Press, 1991.
Частини книг з теми "Facteur de risque génétique":
Brédart, A., A. De Pauw, C. Colas, D. Stoppa-Lyonnet, and S. Dolbeault. "Facteurs de risque génétique." In Psycho-Oncologie de L'adulte, 129–53. Elsevier, 2019. http://dx.doi.org/10.1016/b978-2-294-75811-9.00004-0.
Beckers, J., C. Mayer, E. Bertin, and D. Razavi. "Facteur de risque." In Précis de psycho-oncologie de l'adulte, 35–44. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-07149-2.50003-7.
Brédart, A., A. De Pauw, C. Flahault, D. Stoppa-Lyonnet, and S. Dolbeault. "Facteurs de risques génétiques." In Précis de psycho-oncologie de l'adulte, 45–62. Elsevier, 2008. http://dx.doi.org/10.1016/b978-2-294-07149-2.50004-9.
Hallouët, Pascal. "Les concepts : risque, facteur de risque…" In Méga Mémo IFSI, 901–8. Elsevier, 2016. http://dx.doi.org/10.1016/b978-2-294-74924-7.50113-5.
Labbé, Antoine, Fouzia Mantout, and Christophe Baudouin. "14. La précarité : un facteur de risque pour la vue ?" In Innover contre les inégalités de santé, 195–98. Presses de l’EHESP, 2012. http://dx.doi.org/10.3917/ehesp.brech.2012.01.0195.
Grimaldi, André, and Agnès Hartemann-Heurtier. "L’hyperglycémie post-prandiale est-elle un facteur de risque cardiovasculaire indépendant ?" In Guide pratique du diabète, 60–63. Elsevier, 2009. http://dx.doi.org/10.1016/b978-2-294-70489-5.00009-6.
Bauquier, Charlotte, and Marie Préau. "La sexualité comme facteur de risque et la vaccination contre les papillomavirus humains." In Sexualité, savoirs et pouvoirs, 73–83. Les Presses de l’Université de Montréal, 2019. http://dx.doi.org/10.1515/9782760640900-006.
Kacenelenbogen, Nadine. "Chapitre 7. La séparation parentale, un facteur de risque pour le développement de l’enfant ?" In Les séparations parentales conflictuelles, 101–18. De Boeck Supérieur, 2021. http://dx.doi.org/10.3917/dbu.vande.2021.01.0101.
Тези доповідей конференцій з теми "Facteur de risque génétique":
Romanet, I., J. H. Catherine, P. Laurent, R. Lan, and E. Dubois. "Efficacité de l’ostéotomie interalvéolaire par piezocision : revue de la littérature." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206603010.
Sicard, L., and R. Khonsari. "Conséquences dentaires de la dysjonction pterygo-maxillaire pendant les chirugies d’avancée fronto-faciale monobloc dans le traitement des syndromes de Crouzon." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602001.
Звіти організацій з теми "Facteur de risque génétique":
Corkum, Eleanor, Tiffanie Perrault, and Erin C. Strumpf. Améliorer les parcours de diagnostic du cancer du sein au Québec. CIRANO, October 2023. http://dx.doi.org/10.54932/tlak9928.